![Julian Gilbert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julian Gilbert
Président chez
NUFORMIX PLC
Fortune : 56 216 $ au 30/06/2026
Profil
Julian Clive Gilbert was the founder of Sosei R&D Ltd. (founded in 2000, title: Commercial Director), Acacia Pharma Ltd. (founded in 2006, title: Chief Executive Officer), and Acacia Pharma Group Ltd. (founded in 2007, titled: Chief Executive Officer & Director).
Current jobs include Non-Executive Chairman at Nuformix Plc (since 2022), Chairman at River Biomedics B V I.O.
(since 2022), Director at Nuformix Technologies Ltd. (since 2022), Non-Executive Director at Exvastat Ltd., and Non-Executive Director at Monument Therapeutics Ltd. (since 2021).
Former jobs include Non-Executive Director at IOTA NanoSolutions Ltd., Manager-Business Development at Mundipharma International Ltd., Licensing Executive at BTG Ltd., Head-Formulation Development at Smith Kline & French Laboratories Ltd., and Head-Licensing at Chiroscience Ltd. Education includes undergraduate and doctorate degrees from The University of Nottingham.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUFORMIX PLC 0,9 % | 11/11/2025 | 23 521 428 ( 0,9 % ) | 56 216 $ | 30/06/2026 |
Postes actifs de Julian Gilbert
| Sociétés | Poste | Début |
|---|---|---|
| NUFORMIX PLC | Président | 28/07/2022 |
Monument Therapeutics Ltd.
 Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops precision medicines for central nervous system | Directeur/Membre du Conseil | 01/08/2021 |
Exvastat Ltd.
 Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Operates as a preclinical-stage pharmaceutical company which develops a treatment for acute respiratory distress syndrome | Directeur/Membre du Conseil | - |
River Biomedics B V I.O.
 River Biomedics B V I.O. Medical SpecialtiesHealth Technology Develops human 3D in vitro 3D human heart tissue for pre-clinical drug testing | Président | 01/03/2022 |
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Anciens postes connus de Julian Gilbert
| Sociétés | Poste | Fin |
|---|---|---|
| ACACIA PHARMA GROUP PLC | Fondateur | 31/07/2019 |
IOTA NanoSolutions Ltd.
 IOTA NanoSolutions Ltd. Chemicals: Major DiversifiedProcess Industries Develops organic nanoparticles | Directeur/Membre du Conseil | 10/10/2013 |
Smith Kline & French Laboratories Ltd.
 Smith Kline & French Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Corporate Officer/Principal | - |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Julian Gilbert
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
35
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Health Technology |
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies drugs used in the treatment of neurological disorders | Health Technology |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Provides supportive care product opportunities for post-surgical and cancer patients | Health Technology |
IOTA NanoSolutions Ltd.
IOTA NanoSolutions Ltd. Chemicals: Major DiversifiedProcess Industries Develops organic nanoparticles | Process Industries |
Smith Kline & French Laboratories Ltd.
Smith Kline & French Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Chiroscience Ltd. | |
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Acacia Pharma Group Ltd.
 Acacia Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that engages in developing and commercializing novel products for surgery, invasive procedures & chemotherapy | Health Technology |
Exvastat Ltd.
Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Operates as a preclinical-stage pharmaceutical company which develops a treatment for acute respiratory distress syndrome | Health Technology |
Nuformix Plc
 Nuformix Plc BiotechnologyHealth Technology Develops commercial technologies in pharmaceutical and biotechnology sector | Health Technology |
River Biomedics B V I.O.
River Biomedics B V I.O. Medical SpecialtiesHealth Technology Develops human 3D in vitro 3D human heart tissue for pre-clinical drug testing | Health Technology |
Monument Therapeutics Ltd.
Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops precision medicines for central nervous system | Health Technology |
